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BACKGROUND 
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disease and 
the most frequent disorder in women of reproductive age. Nowadays, PCOS is in the 
focus of research because of its increasing prevalence. PCOS affects approximately 
4-10% of fertile women around the world, but some researchers estimate the overall rate 
to be between 4-25%. The aetiology of this complex and heterogenous disorder is still 
uncertain. Environment factors such as physical inactivity, malnutrition and obesity 
have crucial role in development of the disorder. The most common features of PCOS, 
called the “Rotterdam criteria”, are menstrual disorders (amenorrhoea) such as oligo- or 
anovulatory menstrual cycles; polycystic, large ovaries as detected by ultrasound; and 
clinical or laboratory signs of excess androgen. It often associated with insulin 
resistance (IR) obesity, acne, hirsutism, cardiovascular disorders (CVD). There is a wide 
variability in phenotypes; symptoms and severity vary among affected patients. PCOS 
also alters cardiovascular function through various mechanisms. The mechanisms 
underlying this increased risk and its possible therapeutic approaches are still under 
investigation. IR and obesity were proposed to have a central role in the development of 
CVDs. Although there is a higher incidence of cardiovascular risk factors among PCOS 
patients, the existence of a significantly higher CVD incidence compared to control 
patients is debated. In research yet little is known about cardiovascular alterations of 
PCOS. In the background of PCOS circle vicious of IR and hyperandrogenism can 
increase the risk of CVDs.
Vascular alterations in PCOS. In PCOS, increased arterial stiffness and pulse wave 
velocity  were demonstrated by ultrasound assessments. The mechanism of these 
alterations is unclear, but endothelial dysfunction and altered collagen metabolism of 
the vessel walls may be involved. This is similar to the patterns seen in IR and 
metabolic syndrome. Human studies have shown both macro- and microvascular 
dysfunction measured by  ultrasound in PCOS, as indicated by the reduction in 
acetylcholine(ACh)-dependent vasodilation. This impaired response to ACh is similar to 
that observed in non-insulin-dependent diabetes mellitus. It is proposed to be related to 
metabolic alterations, especially insulin resistance in PCOS. It  was showed that those 
women who have a decreased internal carotid artery  pulsatility  index in PCOS, have a 
higher cardiovascular risk as well. Women with PCOS have a high prevalence of IR, 
metabolic syndrome, early-onset atherosclerosis, and they  might develop hypertension 
during their reproductive period. These abnormalities are partly  explained by the 
pharmacological and biomechanical remodelling of resistance arteries. The intima-
media thickness of the carotid arteries was confirmed to be greater in PCOS than in age- 
and BMI-matched controls. Similarly, coronary artery calcification was found to be 
greater in PCOS patients. An endothelial dysfunction is the first step in the formation of 
atherosclerosis. The exact molecular mechanisms of the vascular alterations in PCOS 
are still unclear. It was hypothesised that the accumulation of reactive oxygen species, 
toxic oxygen-derived products and nitrogen-derived products might contribute to an 
uncontrolled lipid peroxidation of the cell membranes. The stimulation of NADPH 
oxidase and the uncoupling of mitochondrial oxidative phosphorylation can impair NO 
synthesis. These might explain the cardiovascular disorders often seen in PCOS. 
Hyperinsulinemia and IR often associates with PCOS. The independent role of insulin 
in human vessel relaxation has been demonstrated. Insulin induced dilation on efferent 
arterioles in kidney  was reported to be independent of EDRF/NO and prostaglandins, 
however the mechanism of insulin induced direct vascular effect remained unclear. 
Insulin was suggested to affect IP3 release of Ca2+ by a cGMP-dependent mechanism 
that would contribute to its vasodilatory effect. Insulin may  also act through NO and Na
+-K+ ATP-ase in human muscle arterioles. 
Possible role of vitamin D in PCOS. Vitamin D is a secosteroid hormone that  differs 
from other steroid hormones and can be obtained mainly from de novo synthesis in the 
skin. The accompanying metabolic alterations and obesity in PCOS might increase the 
risk of vitamin D deficiency. A recent study showed that vitamin D3 deficiency occurred 
in approximately  72% of PCOS women. The level of vitamin D3 was significantly lower 
in metabolic syndrome, and supplementation during infancy was observed to protect 
against T1DM. Vitamin D deficiency is strongly determined by the degree of obesity, 
and genetic variants of vitamin D3 receptors can enhance the risk of deficiency. A rat 
vitamin D deficiency model was reported in which altered vascular endothelial and 
smooth muscle function and elevated blood pressure were observed. In accordance, 
increased arterial stiffness and endothelial dysfunction were demonstrated to be 
associated with vitamin D insufficiency  in humans. Several researchers suggest that 
vitamin D deficiency may contribute to elevated blood pressure and that  it  has a crucial 
role in the development of hypertension. Direct effect of vitamin D3 on resistance 
vessels was demonstrated earlier by  researchers. However, vitamin D3 supplementation 
was assigned as an adjuvant therapy in PCOS, its effectiveness and possible role on 
metabolic symptoms need to be further characterised. However, even though several 
studies have confirmed the relationship between IR and vitamin D deficiency, the role 
of vitamin D3 in glucose metabolism is still under debate. 
AIMS  
The aim of our study was to induce PCOS by a 70-day-DHT treatment in a modified 
animal model for examining early metabolic and functional changes - the earliest 
detectable lesions. We tried to determine the early effects of DHT treatment on 
carbohydrate metabolism. We examined the potentially  beneficial effects of vitamin D3. 
To identify early mechanical and pharmacological alterations in a morphologically 
stable skeletal muscle resistance vessel such as the gracilis arteriole in rat in PCOS. We 
also investigated the effect  of low-dose vitamin D3 treatment on the vascular 
biomechanical adaptation and the pharmacological responsiveness of the gracilis 
resistance arterioles. We aimed to clarify the effects of DHT on insulin-dependent 
vasodilatation on resistance arterioles to determine associations of the possible 
modulatory role of protective doses of vitamin D3.
METHODS 
Animals. Thirty adolescent (21- to 28-day-old) female Wistar rats that weighed 100-140 
g when the study began were used. Twenty  of the animals received subcutaneous pellets 
containing 7.5 mg DHT implanted under the back skin under anaesthesia (Nembutal 45 
mg/kg i.p. ) in sterile conditions (DHT-treated female groups), which induces polycystic 
ovary syndrome.Ten animals underwent sham operations. Ten DHT-treated animals 
received weekly doses of 120 ng /100 g 1,25 (OH)2 D3 vitamin (DHT+D3 group) 
subcutaneously. A vehicle was given to the remaining 20 animals. The investigation 
conforms to the Principles of Laboratory Animal Care NIH publication No. 85-23, 
revised 1985) as well as the Euroconform Hungarian Law on Animal Care (XXVIII/
1998), and the study  protocol was accepted by the institutional Animal Care 
Commission (IRB approval: 22.1/2960/003/2009). 
Oral Glucose Tolerance Test (OGTT). After eight weeks of treatment, an oral glucose 
tolerance test was performed under short ether narcosis. Blood glucose and plasma 
insulin were measured following overnight fasting and 120 minutes after an oral glucose 
load of  0.3g / 100 g body weight given through a gauge. 
In vivo blood pressure measurement. After ten weeks of DHT treatment blood pressure 
was measured directly  through the carotid artery  in anaesthetised rats (Nembutal 45 mg/
kg i.m.) with a Statham transducer connected to a Cardiosys CO-104 system 
(Experimetria, Budapest, Hungary). 
Biomechanics of a Musculocutanous Arteriole (Pressure Arteriography). After 
opening the iliofemoral region, the arteriole, which had an in vivo diameter of 
approximately 150 µm and is the blood supply for the gracilis muscle, was removed and 
placed into a vessel chamber filled with normal Krebs-Ringer (nKR) solution. It  was 
cannulated at both ends with plastic microcannulas and extended to its in vivo length. 
Both cannulas were connected to pressure-servo pumps, and the arterioles were 
pressurised under a no-flow condition to 50 mmHg intraluminal pressure. The outer and 
the inner diameters of the arterioles were measured by video-microscopic pressure 
microangiometry. In this setup, the glass-bottomed tissue bath was positioned in the 
light path of an inverse Leica microscope. A magnified picture of the vessel was formed 
with the aid of a video camera (Leica DFC320) and Leica QWin software. The 
digitalised pictures were saved, and off-line measurements of the inner and outer 
diameter were made using Leica QWin image analysis software. The gracilis arterioles 
were allowed to equilibrate for 30 minutes at 50 mmHg intraluminal pressure in an 
oxygenised nKR solution. Following incubation, the pressure was decreased to 10 
mmHg and then increased to 100 mmHg in 10-mmHg pressure steps. The steady-state 
diameter was measured. The diameter was also measured during norepinephrine 
contraction after a 10-minute incubation period with 10-6M NE. After recording the NE-
diameter (pre-contraction) at 50 mmHg, dose-diameter curves were recorded in the 
presence of 30, 60, 120, 240 and 600 mU/ml of insulin, leaving an equilibration period 
of 8-10 minutes for each dose, which allowed a stable diameter to be reached and 
measured. After rinsing, NE was added to the organ bath in the same dose as previously 
described. After a 10-minute incubation the pressure-diameter curve was repeated as 
described above.  After recording the NE-curve, at P=50 mmHg, 10-6 M ACh was added 
to the organ bath. Following a 20-minute equilibration period, the outer and inner 
diameters were measured. Next, 10-5 M L-NAME was administered, and the diameters 
were again measured after reaching equilibrium (25-30 minutes at P=50 mmHg). 
Finally, the passive diameter was measured in a Ca2+-free Krebs solution. Arteriolar 
segments were incubated for 20 minutes, and the steady-state, fully relaxed diameter 
was then measured as described above. The effect of insulin + NE was compared to the 
NE-induced contraction without insulin and also was compared to full relaxation. We 
used a micrometre etalon (Wild) for the calibrations. 
Histology. The ovaries were formaldehyde fixed, stained with hematoxylin-eosine and 
histologically examined for controlling PCOS morphology. The morphometry was 
measured using the Pannoramic Viewer software (3DHISTECH Ltd., Budapest, 
Hungary). 
Statistical analysis. For statistical analysis, repeated-measures ANOVA was used. In 
vitro parameters were plotted as a function of intraluminal pressure, and the curves were 
analysed by paired comparisons of the treatment groups. A one-way ANOVA was 
applied for the discrete parameters (e.g., blood pressure) and two way ANOVA for 
analyzing glucose and insulin curves of OGTT. As a post hoc test, Tukey`s test was 
used. P<0.05 was uniformly accepted as a significant difference.
RESULTS 
Physiological parameters. The mean arterial pressure was 122 ± 3 mmHg, 123 ± 6 
mmHg and 123 ± 4 mmHg for the controls, the DHT-group and the DHT+vitamin D3-
treated group, respectively (non-significant). The body weights at the end of the 
experiment were 298 ± 8, 354 ± 16 and 353 ± 9 g for the same groups, respectively. The 
DHT-treated animals had significantly  higher body weights than the controls (p<0.01), 
but there was no difference between the two DHT-treated groups.
Ovarian morphology. We detected a polycystic morphology  in the DHT-treated groups 
and normal ovaries in the controls by  histological analysis. Follicle diameters were 
significantly smaller in DHT-treated ovaries compared to control (1609 ± 617 and 2334 
± 451 pixels at 40x magnification, p<0.05). Follicles of DHT+D3 ovaries weren’t 
significantly different from the other two groups (2054 ± 442). 
Glucose metabolism. The blood glucose levels and the fasting insulin levels were not 
significantly different among the experimental groups. However, significant differences 
were found among the groups for the 120 min postload insulin values (0.71 ± 0.14, 1.42 
± 0.33, 0.48 ± 0.07 ng/ml for C, DHT and DHT+D3). DHT-treated animals had higher 
plasma insulin levels than the controls, and this difference was eliminated by the D3 
vitamin treatment (p<0.001). The fasting and 120 min postload insulin levels were 
significantly different only in the DHT group (p<0.001). Serum fructose amine was 
similar in all groups and within reference range indicating, that the animals did not 
develop diabetes or blood glucose elevation. 
Arteriole geometry. The relaxed outer radii for the different groups were 167 ± 13 µm 
(C), 193 ± 6 µm (DHT) and 166 ± 10 µm (DHT + vitamin D3). The relaxed inner radii 
of the gracilis arterioles were 96 ± 3 µm (DHT), 84 ± 6 µm (C), 83 ± 5 µm (DHT+D3). 
DHT treatment increased both the outer and inner radii, which were diminished by a 
parallel vitamin D3 treatment (p<0.05 for both comparisons). The wall thicknesses for 
the different  groups in the Ca2+-free medium were as follows: 20 ± 2, 19 ± 1, and 20 ± 1 
µm in the control, DHT- and DHT + vitamin D3-treated groups, respectively. In a Ca2+-
free solution, the cross section areas for the vessel walls were 12080 ± 1627, 12542 ± 
1090, and 11348 ± 660 µm2 for these groups, which were not significant. 
Arteriole elasticity. The mechanical load on the vessel wall was measured, and the 
tangential wall stress was significantly higher throughout the entire pressure range for 
the DHT-treated group compared with the other two groups in both a Ca2+-free solution 
and during norepinephrine contraction (p<0.05). Vitamin D3 treatment induced a partial 
reversal of wall stress in the NE-contracted segments and an overcompensation in the 
Ca2+-free solution (both for DHT vs. DHT + D3 and the control vs. DHT + D3, p<0.05). 
Isobaric distensibility  was significantly higher throughout the entire pressure range for 
the DHT group compared with the other two groups in both the Ca2+-free medium and 
during norepinephrine contraction (p<0.05). In response to a parallel treatment with 
vitamin D3, relaxed distensibility fully returned to the control in Ca2+-free solution. 
After NE contraction only a partial recovery was detected in DHT+D3 group. Wall 
elastic moduli were not affected by DHT and vitamin D3 treatment (in a Ca2+-free 
solution, the log elastic moduli were 2.8 ± 0.14, 2.7 ± 0.16 and 2.4 ± 0.11 log(Pa) in the 
control, DHT- and DHT + vitamin D3-treated groups, respectively, ns.). There was no 
difference in the elastic moduli as a function of tangential wall stress. 
Arteriolar contractility DHT treatment significantly  reduced NE tone, which was 
almost fully restored by vitamin D3 treatment (p<0.01 between the control and DHT, 
p<0.05 for the other comparisons). These segments do maintain substantial myogenic 
(spontaneous) tone. The tone was also lower following DHT treatment, and 
interestingly, co-administration of D3 vitamin further decreased myogenic tone (the 
control and DHT-treated rats, p<0.01, as well as the D3 vitamin-treated and untreated 
DHT rats, p<0.05, were significantly different). The sum of the two contractions, which 
represent the ability of the segments to fully contract (range of total pharmacological 
adaptation), was significantly  lower after DHT treatment and was partially  restored by 
vitamin D treatment (the control and DHT-treated rats, p<0.01, as well as the D vitamin-
treated and untreated DHT rats, p<0.05, were significantly different). 
Endothelial dilation. Segments contracted by NE were relaxed in response to 1 µM 
acetylcholine, and this relaxation was significantly  larger in the control compared with 
the DHT-treated group. ACh dilations were severely diminished in the testosterone-
treated female animals. Vitamin D3 treatment did not compensate this alteration but 
produced only a nonsignificant trend toward restoring relaxation. (p<0.05 for both 
treatments comparison with the controls). L-NAME induced substantial contraction in 
the control segments, which was missing in both DHT-treated groups. 
Insulin-induced vascular relaxation of gracilis arterioles Insulin administered to NE-
precontracted gracilis arteriole segments induced concentration-dependent relaxation in 
the control animals. This relaxing effect was much reduced in the DHT-treated group 
(p<0.001). The administration of vitamin D3 partially restored the insulin-induced 
relaxation (p<0.001). Another significant effect  of Vitamin D3 treatment was revealed 
when we compared the NE-induced contractions of segments before and after in vitro 
treatment with elevating concentrations of insulin. Typically, NE-induced contractions 
were more profound after insulin treatment. This difference was reduced in vitamin D3-
treated animals (p<0.05).
DISCUSSION 
As a model of human polycystic ovary syndrome, ten weeks of dihydrotestosterone 
treatment starting during adolescence in female rats induced significant metabolic and 
vascular alterations in our studies. Systemic IR  without altered glucose metabolism was 
developed after 70-day DHT treatment. The two hours insulin value of oral glucose 
tolerance test in the DHT-treated animals was nearly  two times higher than in controls. 
Chronic DHT treatment of female rats, which is an animal model for human PCOS, 
induced significant  alterations in the biomechanical and pharmacological properties of a 
skeletal muscle arteriole. We observed an increase in arteriolar diameter. The relaxed 
lumen was dilated but was not accompanied by  an elevation in wall mass (eutrophic 
remodelling). This elevated wall stress was accompanied by  an increase in isobaric 
distensibility. The elastic moduli did not change, which demonstrates that passive elastic 
element remodelling was limited. There was a substantial alteration in the contractility 
and spontaneous (myogenic) tone of the segments. The additional contraction generated 
by 1 µM NE was reduced in the DHT-treated segments. Endothelial dilation was 
diminished in the DHT-treated groups. The present study demonstrated that insulin-
induced vascular relaxation of arterioles was diminished. These loss of insulin 
dependent dilation of arterioles is the vascular form of IR. While increased IR in human 
PCOS disease and in DHT treated female animals has been described previously, the 
alteration of the well-known vasodilator activity of insulin was not studied. 
Vitamin D3 is an adjuvant therapy  for PCOS, and the cardiovascular protective effect of 
low-dose vitamin D3 therapy is widely accepted. In our study  vitamin D3 therapy was 
demonstrated to reverse systemic IR in our early PCOS model caused by  DHT 
treatment. Vitamin D3 supplementation entirely corrected IR. Chronic vitamin D3 
treatment restored vascular diameter. Our experiments demonstrate that vitamin D3 can 
reverse morphological remodelling, elevation of wall stress and distensibility  in a 
resistance vessel. It improved NE-induced contraction and myogenic tone was further 
reduced. However, loss of endothelial relaxation was unaffected. It was shown that 
changes after DHT treatment are partially counteracted by vitamin D3. Investigation of 
these basic mechanisms revealed that the first effect from a hyperandrogenic state on 
musculocutaneous gracilis arterioles is that NO-dependent relaxation is impaired. 
However, vitamin D3 treatment has no effect on the NO-dependent abnormalities; other 
mechanisms are responsible for compensation. In animals treated with vitamin D3, the 
insulin-evoked relaxation returned to the control level in arterioles. In addition, the 
resistance artery effects of vitamin D3 treatment, which improves both the alterations 
associated with PCOS and IR, had not been investigated yet. 
Our results show basic changes in vascular biomechanics in response to DHT treatment; 
the arteriolar walls become more rigid with increased tangential wall stress compared 
with the controls. However, the tangential wall stress differences that were detected 
even in normotensive animals might be considered prehypertensive abnormalities. The 
enhanced mechanical load of the arteriolar wall is the local factor for the self-
perpetuating, vicious cycle of emerging hypertension. For the decreased spontaneous 
tone observed in the vitamin D3-treated group, tangential wall stress is not elevated. 
This has a local effect  against hypertension development. Thus, the mechanical load of 
the vessels increases. Under passive circumstances, vitamin D3 treatment fully restores 
the biomechanical balance of the vessel wall. However, in response to norepinephrine, 
mechanical load of the vessel wall increases compared with the control group, although 
it does not  reach the level of the DHT-treated group. As a result of the smooth muscle 
pharmacological reactivity changes, the total adaptation range for skeletal muscle 
perfusion significantly decreases in response to DHT treatment. Although vitamin D3 
treatment significantly improves this range, it does not reach the level of the control 
group. In studying the basis for this phenomenon, an obvious, significant decrease in 
NE response is noted after DHT treatment. This is almost restored by vitamin D3 
treatment. A decrease of relaxation is detected in response to DHT treatment. This 
decrease is even more significant when DHT is combined with vitamin D3. Another 
interpretation of these findings is that DHT treatment results in diminished adaptive 
reserve capacity in both directions. Vitamin D3 applied with DHT significantly 
improves pharmacological reactivity  but decreases the vessels’ spontaneous tone even 
compared with the control.
In our experiments, vitamin D3 treatment significantly decreased the vascular IR of 
arterioles caused by DHT. During NE-induced precontraction, DHT treatment decreased 
insulin-dependent relaxation, thus producing vascular IR. However, similar relaxation 
was observed in the control and vitamin D3-treated groups. In response to insulin, the 
NE sensitivity  of the vitamin D3-treated group practically remained unchanged. In the 
control and DHT-treated groups, a 20% increase in contractility was observed after 
rinsing and during the second contraction compared with the first norepinephrine 
contraction. No differences were found between the first and second NE contractions in 
the vitamin D3-treated group, which suggests that vitamin D3 treatment improves NE 
sensitivity. However, the most prominent insulin-dependent relaxation was detected in 
the vitamin D3-treated group. Comparing the insulin-dependent relaxation to ACh 
relaxation, highly significant differences were noted. ACh caused stronger relaxation in 
the control group than in the two treated groups. Moreover, this difference remained the 
same or increased during L-NAME blockade. These results suggest that the relaxing 
effect of insulin is independent from NO in the gracilis arterioles and that vitamin D3 
restores normal vascular tone independently from the NO system.  
CONCLUSIONS 
In this study we used an experimental animal model of PCOS to examine early 
metabolic and vascular lesions. Our results show that the hyperandrogenic state resulted 
in more rigid, less flexible artery  walls. These arteries show reduced endothelium- and 
smooth muscle-dependent vasorelaxation and constriction as well as a complete loss of 
NO-dependent relaxation compared with the controls. In the relaxed vessels, concurrent 
vitamin D3 treatment corrected wall mechanics to the control level. Herein, we provide 
this first data for the effect of vitamin D3 on the mechanical properties of arteries in 
PCOS. This is the first study  investigating the vascular adaptation and insulin sensitivity 
of gracilis arterioles in a PCOS model. This is the first study demonstrating vascular 
insulin resistance of the gracilis arterioles and the counteracting effect of vitamin D3 in 
an experimental PCOS model. The observed alterations of resistance arteries form an 
important prehypertensive pathway of vascular damage in PCOS and might explain the 
observed clinical effectiveness of vitamin D treatment.
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